Intelligent Bio Solutions (INBS) announced its participation as a gold sponsor at the 2025 National Drug and Alcohol Screening Association, NDASA, Conference and Trade Show, taking place from April 1 – 4 in Jacksonville, Florida. Daniel Brown, Head of Clinical Affairs at Intelligent Bio Solutions, will present at the International Symposium on Tuesday, April 1, at 1:00 PM. Daniel will introduce the Company’s Intelligent Fingerprinting Drug Testing Solution, a portable, non-invasive solution designed to enable fast, on-site drug screening using fingerprint sweat. The solution is designed to provide a dignified, efficient alternative to traditional drug testing methods and to support compliance in safety-critical industries. “The NDASA conference brings together key voices in workplace drug testing,” said Daniel Brown, Head of Clinical Affairs at Intelligent Bio Solutions. “We’re proud to support its mission and contribute to the conversation around practical, respectful testing alternatives that address today’s workplace safety challenges.”
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on INBS:
- Intelligent Bio Solutions announces strategic partnership in Spain, Andorra
- Intelligent Bio Solutions Secures U.S. Patent for Drug Screening
- Intelligent Bio Solutions secures U.S. patent, strengthening IP protection
- Intelligent Bio FDA clearance process remains on track for 2025 U.S. launch
- Intelligent Bio Solutions Anticipates Sixth U.S. Patent Approval